Urinary Acylglycine Acylglycine LC LC- -MSMS method MSMS method - - PowerPoint PPT Presentation

urinary acylglycine acylglycine lc lc msms method msms
SMART_READER_LITE
LIVE PREVIEW

Urinary Acylglycine Acylglycine LC LC- -MSMS method MSMS method - - PowerPoint PPT Presentation

Urinary Acylglycine Acylglycine LC LC- -MSMS method MSMS method Urinary Analytical concerns & clinical use Analytical concerns & clinical use R.G.Edwards R.G.Edwards Acylglycine formation formation Acylglycine Glycine


slide-1
SLIDE 1

Urinary Urinary Acylglycine Acylglycine LC LC-

  • MSMS method

MSMS method Analytical concerns & clinical use Analytical concerns & clinical use

R.G.Edwards R.G.Edwards

slide-2
SLIDE 2
slide-3
SLIDE 3

Acylglycine Acylglycine formation formation

  • Glycine

Glycine-

  • N

N-

  • acylase

acylase

  • Acyl

Acyl-

  • CoA

CoA esters conjugated esters conjugated glycine ( glycine (Crn Crn, , GluN GluN) )

  • Polar compounds urine

Polar compounds urine excreted in urine excreted in urine

  • Acylglycines

Acylglycines reflect reflect mitochondrial acyl mitochondrial acyl-

  • CoA

CoA esters esters

  • Acyl

Acyl-

  • CoA

CoA dehydrogenases dehydrogenases

  • Leu

Leu/ Ile/ Val/ Lys catabolism / Ile/ Val/ Lys catabolism

slide-4
SLIDE 4

Propionylglycine Propionylglycine Alloisoleu Suberylglycine Suberylglycine 3 3-

  • Me

Me crotonylglycine crotonylglycine

Biosynthesis of Biosynthesis of Acylglycines Acylglycines

slide-5
SLIDE 5

Method Characteristics Method Characteristics

  • Micromass

Micromass Quattro Micro, Waters 2795 HPLC Quattro Micro, Waters 2795 HPLC

  • Negative ion

Negative ion

  • Urine

Urine ‘ ‘Dilute & shoot Dilute & shoot’ ’, 20 , 20 µ µ L L

  • 2.5 min, isocratic 80%

2.5 min, isocratic 80% AcN AcN

  • Hexanoylglycine

Hexanoylglycine 13

13C

C2

2 (IS)

(IS)

  • 9

9 acylglycines acylglycines; propionyl, ; propionyl, tigly tigly, 3 , 3-

  • methylcrotonyl,

methylcrotonyl, isovaleryl isovaleryl, , 2 2-

  • methylbutyryl,

methylbutyryl, hexanoyl hexanoyl, , octanoyl

  • ctanoyl,

, phenylpropionyl phenylpropionyl, , suberyl suberyl

  • Current use; NNS MCAD urinary hexanoylglycine

Current use; NNS MCAD urinary hexanoylglycine

slide-6
SLIDE 6

Acylglycine Acylglycine excretion excretion

GCDH (decompensated) ~ 202 Glutarylglycine MADD ~ 144 Isobutyryl SCAD, MCAD, MADD ~ 144 Butyryl 75 174.2 C13 Hexanoyl MCAD, {MCT feeds} 74 230.2 Suberyl MCAD 74 206.2 3-phenylpropionyl MCAD, MADD 74 200.3 Octanoyl MCAD, MADD, PCC, BKT, {Valp} 74 172.2 Hexanoyl MADD, SBCAD 74 158.0 2-methylbutyryl IVD, MADD, {EMA-A}, {Valp} 74 158.0 Isovaleryl HMGCL, 3MCC, HLCS, {BKT}, {thiamine def} 74 156.2 3-methylcrotonyl PCC, HLCS, BKT 112 156.1 Tigly (2-mecrotonyl) PCC, MUT, HLCS 74 130.1 Propionyl Enzyme deficiency Daughter ion m/z Parent ion m/z Urine Glycine

slide-7
SLIDE 7

3 3-

  • Methylcrotonylglycine excretion

Methylcrotonylglycine excretion

MCAD MADD PCC b-KT 3MCC Thiamine def Biotinidase IVD

Leucine Leucine catabolism catabolism

*

? TG

slide-8
SLIDE 8

Medium Acyl Medium Acyl-

  • CoA

CoA Dehydrogenase deficiency Dehydrogenase deficiency

PG TG 3-MCG IVG 2-MBG HG OG PPG SG

slide-9
SLIDE 9

MADD & MCAD MADD & MCAD

PG PG TG TG 3MCG 3MCG IVG 2MBG IVG 2MBG HG HG OG OG PPG PPG SG SG

Ile/Leu catabolism Riboflavin responsive can normalise

slide-10
SLIDE 10

Analytical issues Analytical issues

  • Separation of IVG/ 2MBG (TG/3MBG)

Separation of IVG/ 2MBG (TG/3MBG)

  • Deterioration of suberylglycine

Deterioration of suberylglycine

  • Alternative source of pure standards (

Alternative source of pure standards (synth synth SBC) SBC)

  • Appropriate control material

Appropriate control material -

  • ? Spiked, patient

? Spiked, patient

  • Mixed standards for all or some

Mixed standards for all or some glycines glycines

  • Addition of

Addition of butyryl butyryl/ / isobutyryl isobutyryl glycine glycine

slide-11
SLIDE 11

Clinical & Diagnostic Use Clinical & Diagnostic Use

Elevated C4 acylcarnitine Elevated C4 acylcarnitine

  • SCAD

SCAD – – { {butyrylglycine butyrylglycine} (EMA +/ } (EMA +/-

  • MeSuccinate

MeSuccinate) )

  • Isobutyryl

Isobutyryl CoA CoA dehydrogenase dehydrogenase – – isobutyrylglycine isobutyrylglycine

  • EMA encephalopathy

EMA encephalopathy – – isovalerylglycine isovalerylglycine (EMA) (EMA) Elevated C5 acylcarnitine > Elevated C5 acylcarnitine >

  • IVD

IVD -

  • isovalerylglycine

isovalerylglycine

  • SBCAD

SBCAD – – 2 2-

  • methylbutyrylglycine (2

methylbutyrylglycine (2-

  • EHA)

EHA)

  • Equivocal Organic acids &

Equivocal Organic acids & acyls acyls (? (?acylgly acylgly detected) detected)

‘Quick screen method Quick screen method’ ’ Pitt et al. Negative ion method; additional Pitt et al. Negative ion method; additional MRM orotic acid, MRM orotic acid, sulphocysteine sulphocysteine etc. etc.